Skip to content
Tablet Allopathic

Biocal Kit 150 mg+600 mg+400 IU tablet

Generic: Ibandronic Acid + Algae Calcium + Vitamin D3

Company: ACI Limited. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength150 mg+600 mg+400 IU
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated December 18, 2025.

Compare

Same generic, same strength

Sorted by price per tablet. Ask your pharmacist before you switch brands.

Ibandronic Acid + Algae Calcium + Vitamin D3 150 mg+600 mg+400 IU tablets

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Ibandronic Acid + Algae Calcium + Vitamin D3 guide

Indications

This kit is indicated for the treatment and prevention of osteoporosis.

Dosage and administration

Day 1 to Day 10: Take one Calcium & Vitamin D3 tablet daily after meal. Day 11: Take one Ibandronic Acid tablet with a full glass of plain water 1 hour before the breakfast in empty stomach. After taking Ibandronic Acid tablet, patient can usually sit or walk around but must not lie down or take any food or liquid (except plain water) for 1 hour. Day 11 to Day 30: Take one Calcium & Vitamin D3 tablet daily after meal. Use in children and adolescents: Safety and effectiveness in pediatric patients have not been established.

Side effects

Most common side effects are back pain, dyspepsia, pain in extremity, diarrhea, flatulence, constipation, headache, myalgia and upper Gl discomfort.

Precautions and warnings

Ibandronic Acid- Caution should be used when ibandronic acid is given to patients with active upper gastrointestinal problems (such as known Barrett’s esophagus, dysphagia, other esophageal diseases, gastritis, duodenitis or ulcers). Hypocalcemia and other disturbances of bone and mineral metabolism should be treated before starting ibandronic acid therapy. Discontinue ibandronic acid if any patient develop severe bone, joint and muscle pain. If any Patient develops osteonecrosis of the jaw, discontinuation of bisphosphonate therapy should be considered. Any patient presenting with thigh or groin pain should be evaluated to rule out an incomplete femur fracture and interruption of bisphosphonate therapy should be considered. Ibandronic acid is not recommended for use in patients with severe renal impairment (creatinine clearance of

Pregnancy and lactation

There are no data with ibandronic acid use in pregnant women to inform any drug associated risks. This kit is not indicated for use in women of reproductive potential. There is no information on the presence of ibandronate in human milk, the effects of ibandronate on the breastfed infant or the effects of ibandronate on milk production. This kit should not be used during lactation.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250